Scholarlink

Introduction <p>Exosomes/small extracellular vesicles (sEVs) can influence various tissues and cells, and hematopoietic stem cells (HSCs) undergo changes with aging. The present investigation aimed to compare the effects of circulating sEVs derived from old and young subjects on senescence marker expression [reactive oxygen species (ROS), p21 and p53] and antioxidant levels [total antioxidant capacity (TAC), and glutathione (GSH)] in umbilical cord blood-derived hematopoietic stem cells (HSCs) for the first time.</p> Methods <p>Exosomes/sEVs were obtained from four old (O-Exo) and four young (Y-Exo) men and characterized for CD63 expression, zeta potential, size and morphology. The cells were treated with pooled sEVs (5 and 10&#xa0;µg/mL), and cell viability (using MTT assay), <i>p53</i> and <i>p21</i> gene expression (by qRT-PCR), TAC, GSH (kit-based), and ROS (using flow cytometry) were assessed. P53 protein levels were analyzed by Western blot method.</p> Results <p>HSCs treated with elderly-derived sEVs (5&#xa0;µg/mL [O5-Exo] and 10&#xa0;µg/mL [O10-Exo]) exhibited significantly elevated P53 (<i>P</i> = 0.022) and P21 (<i>P</i> = 0.002) mRNA expression compared to the control group. Among all treatment groups, the O10-Exo group demonstrated the most significant upregulation of P53 protein expression (<i>P</i> &lt; 0.05). Compared to the control, ROS levels were significantly increased in HSCs treated with 5&#xa0;µg/mL (<i>P</i> = 0.022) and 10&#xa0;µg/mL (<i>P</i> = 0.002) elderly sEVs. Both O5-Exo and O10-Exo treatments significantly decreased GSH and TAC levels in HSCs relative to controls (<i>P</i> &lt; 0.005).</p> Conclusion <p>Our data demonstrated that sEVs from aged donors significantly upregulated senescence markers (P53, P21) and oxidative stress (ROS) while depleting antioxidant defenses (TAC, GSH) in HSCs compared to young-derived exosomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Circulating Small Extracellular Vesicles of Aged Individuals Promote Higher Senescence Marker Expression and Lower Antioxidant Levels in Hematopoietic Stem Cells

  • 期刊论文

  • 发表日期：

    2026年1月14日

查看全文
  • Reza Afrisham,
  • Mohammad Ahmadvand,
  • Sahar Sadegh-nejadi,
  • Zahra Kashanikhatib,
  • Saeed Kaviani,
  • Vida Farrokhi,
  • Maryam Helali,
  • Shaban Alizadeh

摘要

Introduction

Exosomes/small extracellular vesicles (sEVs) can influence various tissues and cells, and hematopoietic stem cells (HSCs) undergo changes with aging. The present investigation aimed to compare the effects of circulating sEVs derived from old and young subjects on senescence marker expression [reactive oxygen species (ROS), p21 and p53] and antioxidant levels [total antioxidant capacity (TAC), and glutathione (GSH)] in umbilical cord blood-derived hematopoietic stem cells (HSCs) for the first time.

Methods

Exosomes/sEVs were obtained from four old (O-Exo) and four young (Y-Exo) men and characterized for CD63 expression, zeta potential, size and morphology. The cells were treated with pooled sEVs (5 and 10 µg/mL), and cell viability (using MTT assay), p53 and p21 gene expression (by qRT-PCR), TAC, GSH (kit-based), and ROS (using flow cytometry) were assessed. P53 protein levels were analyzed by Western blot method.

Results

HSCs treated with elderly-derived sEVs (5 µg/mL [O5-Exo] and 10 µg/mL [O10-Exo]) exhibited significantly elevated P53 (P = 0.022) and P21 (P = 0.002) mRNA expression compared to the control group. Among all treatment groups, the O10-Exo group demonstrated the most significant upregulation of P53 protein expression (P < 0.05). Compared to the control, ROS levels were significantly increased in HSCs treated with 5 µg/mL (P = 0.022) and 10 µg/mL (P = 0.002) elderly sEVs. Both O5-Exo and O10-Exo treatments significantly decreased GSH and TAC levels in HSCs relative to controls (P < 0.005).

Conclusion

Our data demonstrated that sEVs from aged donors significantly upregulated senescence markers (P53, P21) and oxidative stress (ROS) while depleting antioxidant defenses (TAC, GSH) in HSCs compared to young-derived exosomes.